AbbVie Inc. (ABBV) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	66.0B	61.2B	56.3B	54.3B	58.1B
Cost of Revenue	15.7B	18.2B	16.9B	20.4B	17.4B
Gross Profit	50.3B	43.0B	39.4B	33.9B	40.6B
Operating Expenses
R&D Expense	10.0B	9.1B	12.8B	7.7B	6.5B
SG&A Expense	15.2B	14.0B	14.8B	12.9B	15.3B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	1.7B	(241.0M)	2.8B	599.0M	753.0M
Total Operating Expenses	26.9B	22.9B	30.3B	21.1B	22.5B
Cost and Expenses	42.6B	41.1B	47.2B	41.6B	39.9B
Operating Income (EBIT)	23.5B	20.1B	9.1B	12.8B	18.1B
Non-Operating
Interest Income	198.0M	266.0M	648.0M	540.0M	186.0M
Interest Expense	2.9B	2.9B	2.8B	2.2B	2.2B
Net Interest Income	(2.7B)	(2.6B)	(2.2B)	(1.7B)	(2.0B)
Other Non-Op Income/Expense	(10.6B)	(13.5B)	(5.4B)	(6.5B)	(4.6B)
Non-Operating Income (excl Interest)	5.1B	10.6B	2.6B	4.3B	2.4B
EBT (Pre-Tax Income)	12.8B	6.6B	3.7B	6.3B	13.5B
Income Tax Expense	2.5B	2.4B	(570.0M)	1.4B	1.6B
Bottom Line
Net Income	10.3B	4.2B	4.3B	4.9B	11.8B
Earnings from Cont. Ops	10.3B	4.2B	4.3B	4.9B	11.8B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	10.3B	4.2B	4.2B	4.8B	11.8B
Per Share
Basic EPS	$5.83	$2.37	$2.40	$2.73	$6.65
Diluted EPS	$5.83	$2.37	$2.39	$2.72	$6.63
Revenue Per Share	$37.25	$34.48	$31.85	$30.72	$32.78
Shares
Basic Shares Outstanding	1.8B	1.8B	1.8B	1.8B	1.8B
Diluted Shares Outstanding	1.8B	1.8B	1.8B	1.8B	1.8B
Profitability Metrics
EBITDA	24.1B	17.6B	14.9B	17.2B	24.2B
D&A	5.8B	8.1B	8.4B	8.7B	8.5B
EBIT	18.3B	9.5B	6.5B	8.5B	15.7B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026